MONTREAL, /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, ...
Moxifloxacin (MX) is an 8-methoxyquinolone antimicrobial drug, which is often used as a positive control in thorough QT (TQT) studies. In the present study we established the population ...
February 19, 2009 (Portland, Oregon) — Both diabetes and QT-interval-prolonging medications were significant and independent risk factors for sudden cardiac death (SCD) among members of a ...
NEW YORK--(BUSINESS WIRE)--AccurKardia, a software company that provides clinical-grade, device agnostic, automated ECG (“electrocardiogram”) analytics, today announced the first study showcasing the ...
CIN-102, Deudomperidone, is a novel, deuterium-containing, peripherally selective dopamine (D2/D3) receptor antagonist. Study demonstrated that therapeutic and ~5-fold supra-therapeutic concentrations ...
Aim To determine factors affecting the QT interval in athletes and find an improved means of QT correction (QTc) Method Data was gathered from the CAYA (Cardiovascular Assessment in Young Athletes) ...
February 9, 2010 (Dallas, Texas and Washington, DC) — Many common, useful drugs have the side effect of electrocardiographic QT-interval prolongation, which substantially increases the risk of sudden ...
As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...
An asymptomatic male patient with definite LQTS with a normal ECG and QTc who was flagged by the AI. Photo Credit: J. Martijn Bos and Michael Ackerman. A new artificial intelligence (AI) solution ...
1 Department of Pediatrics/Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota, USA 2 Department of Medicine/Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA ...
Researchers have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. Researchers from Mayo Clinic and AliveCor Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback